Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019875 · ClinicalTrials.gov registry record · Early Phase 1
CYP3A4 Activity and Mineral Homeostasis
A Early Phase 1 study of Vitamin D and Calcium Homeostasis, sponsored by University of Washington.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT02019875 is a Early Phase 1 study of Vitamin D and Calcium Homeostasis that has completed, run by University of Washington. The registered enrollment target is 92 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02019875, a Early Phase 1 study of Vitamin D and Calcium Homeostasis, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether changes in the activity of the enzyme CYP3A4 can change the Vitamin D and bone mineral homeostasis.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Rifampin
- DRUG Clarithromycin
- OTHER Grapefruit Juice
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2014-06 |
| Est. Completion | 2020-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019875
The ClinicalTrials.gov registry entry for NCT02019875 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vitamin D and Calcium Homeostasis appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT02019875 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT02019875 about?
NCT02019875 is a clinical study titled "CYP3A4 Activity and Mineral Homeostasis". The purpose of this study is to determine whether changes in the activity of the enzyme CYP3A4 can change the Vitamin D and bone mineral homeostasis.
What is the current status of trial NCT02019875?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 92 participants. The study started on 2014-06. Estimated completion is 2020-12.
What conditions does trial NCT02019875 study?
This clinical trial studies the following conditions: Vitamin D and Calcium Homeostasis.
What interventions are being tested in trial NCT02019875?
The interventions under investigation include: Placebo (OTHER), Rifampin (DRUG), Clarithromycin (DRUG), Grapefruit Juice (OTHER).
Who is sponsoring clinical trial NCT02019875?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02019875 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.